A Study of RPL554 Drug Administered by Metered Dose Inhaler to Treat Chronic Obstructive Pulmonary Disease

Condition:   COPD Interventions:   Drug: Ensifentrine 100mcg;   Drug: Ensifentrine 300mcg;   Drug: Ensifentrine 1000mcg;   Drug: Ensifentrine 3000mcg;   Drug: Ensifentrine 6000mcg;   Drug: Placebos Sponsors:   Verona Pharma plc;   Iqvia Pty Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials